Skip to main content
Premium Trial:

Request an Annual Quote

Dana-Farber Cancer Scientists to Use HistoRx's Biomarker Profiling Tech

NEW YORK (GenomeWeb News) – Researchers at the Dana-Farber/Harvard Cancer Center will use HistoRx’s Aqua biomarker profiling technology in cancer studies and cancer treatment research, the company said Thursday.
More than 900 researchers at DF/HCC will use the company’s PM-2000 tissue analysis tool, which was purchased by Brigham and Women’s Hospital for its pathology core facility in 2005.
The core facility is a service center that provides tissue-based tests and analysis for several institutions, including Brigham and Women’s Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Harvard School of Public Health, Children’s Hospital Boston, Beth Israel Deaconess Hospital, and Massachusetts General Hospital.
The company’s Aqua technology is used to measure biomarker concentration with subcellular resolution in order to understand the safety and effectiveness of new drugs and companion diagnostics.
The PM-2000 system is used to measure protein biomarkers in tissue and in tissue microarrays that are based on fluorescent immunohistochemical methods.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.